Latest BPH Stories
Prostatic Artery Embolization: Study Shows Symptom Improvement Comparable to "Gold Standard" Transurethral Resection of the Prostate--Without Surgical Risks of Sexual Dysfunction, Urinary Incontinence, Blood Loss, Retrograde Ejaculation CHICAGO, March 29, 2011 /PRNewswire-USNewswire/ -- A new interventional radiology treatment that blocks blood supply to men's enlarged prostate glands shows comparable clinical results to transurethral resection of the prostate (or TURP), considered the gold...
PLEASANTON, Calif., March 22, 2011 /PRNewswire/ -- NeoTract, Inc. a medical device company focused on developing urology devices, today announced that the first U.S. patients have been enrolled in a multinational trial of its UroLiftÂ® System at Western Urological Clinic in Salt Lake City, Utah.
CHARLOTTESVILLE, Va., Feb.
Researchers from Boston University School of Medicine (BUSM), in collaboration with colleagues at Lahey Clinic and from Denmark and Germany, have found that 5a-reductase inhibitors (5a-RIs), while improving urinary symptoms in patients with benign prostatic hyperplasia (BPH) and possible hair loss prevention, produces significant adverse effects in some individuals including loss of libido, erectile dysfunction (ED), ejaculatory dysfunction and potential depression.
A cholesterol-lowering drug reduced the enlarged prostates of hamsters to the same extent as a drug commonly used to treat benign prostatic hyperplasia (BPH).
MINNETONKA, Minn., Oct.
VANCOUVER, Sept. 29 /PRNewswire-FirstCall/ - Protox Therapeutics Inc.
NEVILLEWOOD, Pa., July 12 /PRNewswire/ -- A new study, published in the July issue of Advances in Therapy, revealed that a novel saw palmetto extract (SPE), SPET-085, is as effective as finasteride, the standard prescription drug therapy, in blocking the critical enzyme that leads to benign prostatic hyperplasia (BPH).
A 17-year-long community study looking at symptoms of enlarged prostate in over 2,000 men age 40 to 79 years suggests that surgery for benign prostatic hyperplasia (BPH) offers more relief from incontinence and obstruction symptoms than treatment from drug-based therapy.
BEIJING, April 29, /PRNewswire/ -- Realton Corporation, a pioneer in developing diode-pumped laser systems initially targeted to treat enlarged prostate, today announced the closing of its Series B financing co-led by OrbiMed Advisors and China Healthcare Partnership (CHP, a fund under Martin Currie Asset Management Group).
- Small missiles, especially grape, canister, fragments of iron, and the like, when fired, as upon an enemy at close quarters.
- To fire mitraille at.